Skip to main content
Top
Published in: Current Treatment Options in Gastroenterology 4/2019

01-12-2019 | Helicobacter Pylori | Stomach (P Malfertheiner, Section Editor)

Initiatives for a Healthy Stomach

Author: Chun-Ying Wu

Published in: Current Treatment Options in Gastroenterology | Issue 4/2019

Login to get access

Abstract

Purpose of review

The stomach is not only a major digestive organ, but also a sophisticated endocrine organ and an essential microbial defense organ. Stomach diseases, such as peptic ulcer diseases, stomach cancer, and functional dyspepsia, are important health burden worldwide. However, the public awareness about the stomach health and diseases are relatively low.

Recent findings

To promote the awareness of medical professionals and also the general population on stomach health and diseases, the healthy stomach initiatives (HSI) was established in 2012. The HSI is very active in promoting international collaboration studies and public awareness events focused on stomach health and diseases. The HSI chose October 2 as the “World Stomach Day” to promote public awareness, to invite physician involvement, to increase scientific research, to apply government support, and to get industrial sponsorship. The first World Stomach Day was celebrated in Taipei in 2018 with very successful public educational activities.

Summary

To promote the study of stomach diseases and the public awareness of stomach health is an important work. The HSI and the World Stomach Day will play essential roles in this work.
Literature
1.
go back to reference Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol. 2001;63:119–39.CrossRef Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol. 2001;63:119–39.CrossRef
2.
go back to reference • Hunt RH, Camilleri M, Crowe SE, et al. The stomach in health and disease. Gut. 2015;64:1650–68 This study provides a thorough review of the stomach functions and the pathophysiology of stomach diseases.CrossRef • Hunt RH, Camilleri M, Crowe SE, et al. The stomach in health and disease. Gut. 2015;64:1650–68 This study provides a thorough review of the stomach functions and the pathophysiology of stomach diseases.CrossRef
3.
go back to reference Burger KS, Berner LA. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav. 2014;136:121–7.CrossRef Burger KS, Berner LA. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav. 2014;136:121–7.CrossRef
4.
go back to reference Goyal RK, Guo Y, Mashimo H. Advances in the physiology of gastric emptying. Neurogastroenterol Motil. 2019;31:e13546.CrossRef Goyal RK, Guo Y, Mashimo H. Advances in the physiology of gastric emptying. Neurogastroenterol Motil. 2019;31:e13546.CrossRef
5.
go back to reference Espinoza JL, Matsumoto A, Tanaka H, Matsumura I. Gastric microbiota: an emerging player in helicobacter pylori-induced gastric malignancies. Cancer Lett. 2018;414:147–52.CrossRef Espinoza JL, Matsumoto A, Tanaka H, Matsumura I. Gastric microbiota: an emerging player in helicobacter pylori-induced gastric malignancies. Cancer Lett. 2018;414:147–52.CrossRef
6.
go back to reference Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol. 2017;2:298–312.CrossRef Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol. 2017;2:298–312.CrossRef
7.
go back to reference Tseng CH, Lin JT, Ho HJ, et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep. 2016;6:20701.CrossRef Tseng CH, Lin JT, Ho HJ, et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep. 2016;6:20701.CrossRef
8.
9.
go back to reference Wu CY, Lin JT. The changing epidemiology of Asian digestive cancers: from etiologies and incidences to preventive strategies. Best Pract Res Clin Gastroenterol. 2015;29:843–53.CrossRef Wu CY, Lin JT. The changing epidemiology of Asian digestive cancers: from etiologies and incidences to preventive strategies. Best Pract Res Clin Gastroenterol. 2015;29:843–53.CrossRef
10.
go back to reference Wu CY, Wu CH, Wu MS, Wang CB, Cheng JS, Kuo KN, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7:427–31.CrossRef Wu CY, Wu CH, Wu MS, Wang CB, Cheng JS, Kuo KN, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7:427–31.CrossRef
11.
go back to reference Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–42.CrossRef Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–42.CrossRef
12.
go back to reference Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. 2012;56:698–705.CrossRef Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. 2012;56:698–705.CrossRef
13.
go back to reference •• Venerito M, Vasapolli R, Rokkas T, et al. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter. 2018;23(Suppl 1):e12518 This article provides an excellent review for gastric cancer from its health burden, to prevention and treatment.CrossRef •• Venerito M, Vasapolli R, Rokkas T, et al. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter. 2018;23(Suppl 1):e12518 This article provides an excellent review for gastric cancer from its health burden, to prevention and treatment.CrossRef
14.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef
15.
go back to reference Helicobacter, Cancer Collaborative G. Gastric cancer and helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.CrossRef Helicobacter, Cancer Collaborative G. Gastric cancer and helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.CrossRef
16.
go back to reference Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009;137:1641–8 e1–2.PubMed Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009;137:1641–8 e1–2.PubMed
17.
go back to reference Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–1124 e5.PubMed Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–1124 e5.PubMed
18.
go back to reference Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.CrossRef Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.CrossRef
19.
go back to reference Hadizadeh F, Bonfiglio F, Belheouane M, Vallier M, Sauer S, Bang C, et al. Faecal microbiota composition associates with abdominal pain in the general population. Gut. 2018;67:778–9.PubMed Hadizadeh F, Bonfiglio F, Belheouane M, Vallier M, Sauer S, Bang C, et al. Faecal microbiota composition associates with abdominal pain in the general population. Gut. 2018;67:778–9.PubMed
20.
go back to reference Zhong L, Shanahan ER, Raj A, Koloski NA, Fletcher L, Morrison M, et al. Dyspepsia and the microbiome: time to focus on the small intestine. Gut. 2017;66:1168–9.CrossRef Zhong L, Shanahan ER, Raj A, Koloski NA, Fletcher L, Morrison M, et al. Dyspepsia and the microbiome: time to focus on the small intestine. Gut. 2017;66:1168–9.CrossRef
Metadata
Title
Initiatives for a Healthy Stomach
Author
Chun-Ying Wu
Publication date
01-12-2019
Publisher
Springer US
Published in
Current Treatment Options in Gastroenterology / Issue 4/2019
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-019-00266-x

Other articles of this Issue 4/2019

Current Treatment Options in Gastroenterology 4/2019 Go to the issue

Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Immune-Mediated Colitis

Nutrition and Obesity (O Pickett-Blakely, Section Editor)

Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence

Obesity and Nutrition (O Pickett-Blakely, Section Editor)

An Approach to Obesity Management for Gastroenterologists and Hepatologists

Gastroenterology for Geriatric Patients (S Katz and A Afzali, Section Editors)

Vaccination in the Elderly and IBD

Obesity and Nutrition (O Pickett-Blakely, Section Editor)

The Gluten-Free Diet: Use in Digestive Disease Management